Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 3Uveal Melanoma 1Stomach Neoplasms 1Rectal Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Gallbladder Neoplasms 1Esophageal Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Renal Cell 1Bile Duct Neoplasms 1Adenocarcinoma Of Esophagus 1

Interventions

Gemcitabine 8Fluorouracil 5Cisplatin 5Leucovorin 4Oxaliplatin 3becatecarin 2Capecitabine 2seribantumab 1sargramostim 1pembrolizumab 1pazopanib 1motexafin lutetium 1ixabepilone 1irinotecan sucrosofate 1incomplete Freund's adjuvant 1durvalumab 1devimistat 1cediranib 1Trastuzumab 1Sorafenib 1Radiosurgery 1Psychiatric Rehabilitation 1Palonosetron 1Observation 1Liver Transplantation 1Folfox protocol 1Escitalopram 1Erlotinib Hydrochloride 1Carboplatin 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Gallbladder Neoplasms × incomplete Freund's adjuvant × Clear all
NCT00012246 2013-05-16

Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract

The University of Texas Medical Branch, Galveston

Phase 2 Terminated
7 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Bile Duct Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡